Ideaya Biosciences
Price & Volume
Stats
See more52W Range | $13.45-$37.08 |
Market Cap | $3B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $214.8M |
Revenue Growth (YoY) | 78.5% |
Gross Profit (12 Mos) | -$153.4M |
Diluted EPS | -$1.89 |
News
See moreYahoo Finance • 9 days ago
IDEAYA Secures IND Clearance For IDE034 In Solid Tumors
Yahoo Finance • 12 days ago
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 3 months ago
10 most overbought S&P 500 stocks ahead of PPI and CPI data
Yahoo Finance • 3 months ago
KNDS CEO is said to see 2026 IPO as 'realistic' path to expansion
About
CEO | Mr. Yujiro S. Hata |
Address | 5000 Shoreline Court, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 131 |
